glp-1 drugs approved for weight loss from the Gray Market GLP-1s in the “Barbecue Belt

doi: 10.1111/obr.13046 143 SetjiTLBrownAJ

Back Gilbert, B, Rosenthal, D (21 Jan 2024) 'The complete history & strategy of Novo Nordisk: Novo Nordisk (Ozempic)', Acquired podcast, Season 14, Episode 1

22 However, the fact that the magnitude and speed of hemoglobin A1c reduction with treatment were identified as risk factors for progression suggests it could be another example of the well-established early worsening phenomenon first observed in type 1 diabetic patients intensively treated with insulin in the Oslo Study, Kroc Collaborative Study and Diabetes Control and Complications Trial

Lancet 392, 15191529 (2018)